Top

14-05-2024 | Semaglutide | Commentary

Paired Comment Regarding Early Successful Experiences of Surgical Conversion of Endoscopic Gastric Plication to Roux-en-Y gastric Bypass

Author: Carlos Aurelio Schiavon

Excerpt

In this issue, Shin T et al. [1] present the largest description (four cases) of a single-stage conversion of Primary Obesity Surgery Endoluminal procedure (POSE) to Roux-en-Y Gastric Bypass (RYGB). The authors describe the feasibility with technical highlights in a video, the preoperative approach for this special population, and the medium-term postoperative outcomes [1]. …

Obesity surgery. http://secure-web.cisco.com/1VYeXf-6Eb-.

Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity. 2017;25(2):294–301. https://doi.org/10.1002/oby.21702.CrossRefPubMed

Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400(10350):441–51. https://doi.org/10.1016/S0140-6736(22)01280-6.CrossRefPubMed

Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. https://doi.org/10.1056/NEJMoa2032183.CrossRefPubMed

Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–16. https://doi.org/10.1056/NEJMoa2206038.CrossRefPubMed

Clapp B, Wynn M, Martyn C, et al. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. 2018;14(6):741–7. https://doi.org/10.1016/j.soard.2018.02.027.CrossRefPubMed

Khoursheed M, Al-Ali J, Fingerhut A. Laparoscopic sleeve gastrectomy after endoscopic sleeve gastroplasty and primary obesity surgery endoluminal: technical aspects. Surg Obes Relat Dis. 2020;16(9):1370–1. https://doi.org/10.1016/j.soard.2020.06.017.CrossRefPubMed

Beitner M, Hopkins G. Conversion of endoscopic sleeve gastroplasty to laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2020;16(4):590–1. https://doi.org/10.1016/j.soard.2019.12.026.CrossRefPubMed

Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221–32. https://doi.org/10.1056/NEJMoa2307563.CrossRefPubMed

10.

Haddad A, Kow L, Herrera MF, et al. Innovative bariatric procedures and ethics in bariatric surgery: the IFSO position statement. Obes Surg. 2022;32(10):3217–30. https://doi.org/10.1007/s11695-022-06220-8.CrossRefPubMed

Title: Paired Comment Regarding Early Successful Experiences of Surgical Conversion of Endoscopic Gastric Plication to Roux-en-Y gastric Bypass
Author: Carlos Aurelio Schiavon
Publication date: 14-05-2024
Publisher: Springer US
Keywords: Semaglutide
Obesity
Obesity
Published in: Obesity Surgery
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-024-07272-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Paired Comment Regarding Early Successful Experiences of Surgical Conversion of Endoscopic Gastric Plication to Roux-en-Y gastric Bypass

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content